Donald Trump's tariff move impacts Indian pharma stocks. Companies like Sun Phar...
With the US accounting for nearly 35% of India’s overall pharma shipments of ove...
Stock market recommendations: Mirae Asset Sharekhan's Somil Mehta recommends buy...
Pharmaceutical stocks, particularly Indian firms, plummeted following President ...
Indian pharmaceutical giants like Sun Pharma, Torrent, and Dr. Reddy's have laun...
India Ratings and Research (Ind-Ra) anticipates minimal credit profile impact on...
US President Donald Trump has said his administration will impose 100 per cent i...
US President Trump announced a 100% tariff on imported branded and patented phar...
Indian firm Natco Pharma is set to acquire substantial stakes in South African p...
Semaglutide patent expiries in India, Canada, and Brazil are poised to unlock ov...
Industry leaders in pharma and MedTech are urging the government to establish a ...
An interim India-US trade arrangement offers clarity to India's pharma sector, k...
The Dadachanji Group has launched KAIRISH Innotech, venturing into custom-built ...
Asian drug stocks faced a downturn. This followed US President Trump's tariff th...
Dalal Street plunged this week, with over 440 BSE 500 stocks in red, following U...
India's top-10 companies saw their combined market valuation shrink by nearly Rs...